Journals / İnfeksiyon Dergisi / 2005 / Cilt: 19 - Sayı: 2

A case of fever of unknown origin late diagnosed

Geç tanı alan nedeni bilinmeyen bir ateş olgusu

Pages
253–258
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is concluded that the examination of repeated bone marrow biopsy specimens can lead to the diagnosis of non-Hodgkin lymphoma in patients with FUO.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The cause of fever of unknown origin (FUO) cannot be determined in 7-14% of patients with fever despite all available diagnostic interventions.
📊
Key Findings & Data:This is a report on a case of non-Hodgkin lymphoma diagnosed following third bone morrow biopsy, 16 months after his admission.
💡
Conclusion & Impact:It is concluded that the examination of repeated bone marrow biopsy specimens can lead to the diagnosis of non-Hodgkin lymphoma in patients with FUO.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The cause of fever of unknown origin (FUO) cannot be determined in 7-14% of patients with fever despite all available diagnostic interventions. It has been reported that long term prognosis of this patient group is good. This is a report on a case of non-Hodgkin lymphoma diagnosed following third bone morrow biopsy, 16 months after his admission. It is concluded that the examination of repeated bone marrow biopsy specimens can lead to the diagnosis of non-Hodgkin lymphoma in patients with FUO.

Özet

Tüm tanısal girişimlere değin nedeni bilinmeyen ateş (NBA) olgularının %7-14'ünde ateşin nedeni bulunamamaktadır. Birçok çalışmada bu olguların prognozunun iyi olduğu bildirilmektedir. Bu yazıda, uzun süreli ateşinin (16 ay) nedeni bulunamayan ve ancak üçüncü kemik iliği biyopsisinde non-Hodgkin İenfoma tanısı alan 70 yaşında erkek hasta sunulmuştur. Tekrarlayan kemik iliği biyopsi örneklerinin incelenmesinin NBA'lı olgularda İenfoma tanısını koymada yardımcı olabileceği sonucuna varılmıştır.

🔖

Cite This Article

TOMBULOĞLU, M., ÇALIK, Ş., KARAKARTAL, G., OĞUZ, S., BÜKE, Ç., SİPAHİ, O. R. (2022). A case of fever of unknown origin late diagnosed. İnfeksiyon Dergisi, Cilt: 19 - Sayı: 2, 253–258. https://ajindex.com/articles/546511

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Durack DT, Street AC. Fever of unknown origin - reexamined and redefined. Curr Clin Top Infect Dis 1991; 11: 35-51
  2. Pehlivan M, Biberoğlu K, Tahran O, Kundak I, Özcan MA. Nedeni bilinmeyen ateş: 62 olgu bildirisi. Flora 1998; 3: 113-9
  3. Saltoğlu N, Taşova Y, Midikli D, Aksu HS, Sanli A, Dündar IH. Fever of unknown origin in Turkey: evaluation of 87 cases during a nine-year- period of study. J Infect 2004; 48: 81 -5
  4. Tabak F, Mert A, Çelik AD ve ark. Fever of unknown origin in Turkey. Infection 2003; 31:417-20
  5. Petersdorf RB, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine 1961; 40:1-30
  6. Mourad O, Palda V, Detsky AS. A comphrensive evidence-based approach to fever of unknown origin. Arch Intern Med 2003; 163: 545-51
  7. Knockaert DC, Vanderschueren S, Blockmans D. Fever of unknown origin in adults: 40 years on. J Int Med 2003; 253: 265-275
  8. Ergonul O, Willke A, Azap A, Tekeli E. Revised definition of 'fever of unknown origin': limitations and opportunities. J Infect 2005; 50:1-5
  9. Goldschmidt N, Gural A, Kornberg A, Spectre G, Shopen A, Paltiel O. Prolonged fever of unknown origin and hemophagocytosis evolving into acute lymphoblastic leukemia. Am J Hematol 2004; 76: 364-7
  10. Mortensen JC, Lindberg JA. Bone marrow disease revealed by leukocyte scintigraphy in a patient with relapsing fever of unknown origin. Ugeskr Laeger 1994; 156:3503-4
  11. Bartl R, Hansmann ML, Frisch B, Burkhardt R. Comparative histology of malignant Iymphomas in lymph node and bone marrow. BrJ Haematol 1988; 69: 229-37
  12. Seewann HL. Jamshidi biopsy in clinical hematology. Method, indications and results of over 1,000 completed biopsies with special reference to chronic myeloproliferative diseases. Wien Med Wochenschr 1986; 100 (Suppl): 1-24
  13. Ebie N, Loew JM, Gregory SA. Bilateral trephine bone marrow biopsy for staging non-Hodgkin's lymphoma—a second look. Hematol Pathol 1989; 3: 29-33
  14. Sah SP, Matutes E, Wotherspoon AC, Morilla R, Catovsky D. A comparison of flow cytometry, bone marrow biopsy, and bone marrow aspirates in the detection of lymphoid infiltration in B cell disorders. J Clin Pathol 2003; 56:129-32.